Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar spud2288 (< 20) Submitted: 10/25/2010 10:34:29 AM : Outperform Start Price: $3.66 SVA Score: -62.51

Vaccine production

Featured Broker Partners


Advertisement